drugset / Trial / NCT02973100
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of investigational doses of dulaglutide in participants with type 2 diabetes on metformin monotherapy.
Timeline
- Start
- 2016-12
- Primary completion
- 2017-07-15
- Completion
- 2017-08-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dulaglutide | Peptide | 1.5 mg | Subcutaneous |
| Subject | Dulaglutide | Peptide | 3 mg | Subcutaneous |
| Subject | Dulaglutide | Peptide | 4.5 mg | Subcutaneous |